These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 18421000)

  • 1. Acute elevation of plasma PLTP activity strongly increases pre-existing atherosclerosis.
    Moerland M; Samyn H; van Gent T; van Haperen R; Dallinga-Thie G; Grosveld F; van Tol A; de Crom R
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1277-82. PubMed ID: 18421000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development.
    Vikstedt R; Ye D; Metso J; Hildebrand RB; Van Berkel TJ; Ehnholm C; Jauhiainen M; Van Eck M
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):578-86. PubMed ID: 17170377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression.
    Valenta DT; Ogier N; Bradshaw G; Black AS; Bonnet DJ; Lagrost L; Curtiss LK; Desrumaux CM
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1572-8. PubMed ID: 16675720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage phospholipid transfer protein deficiency and ApoE secretion: impact on mouse plasma cholesterol levels and atherosclerosis.
    Liu R; Hojjati MR; Devlin CM; Hansen IH; Jiang XC
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):190-6. PubMed ID: 17038631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Worsening of diet-induced atherosclerosis in a new model of transgenic rabbit expressing the human plasma phospholipid transfer protein.
    Masson D; Deckert V; Gautier T; Klein A; Desrumaux C; Viglietta C; Pais de Barros JP; Le Guern N; Grober J; Labbé J; Ménétrier F; Ripoll PJ; Leroux-Coyau M; Jolivet G; Houdebine LM; Lagrost L
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):766-74. PubMed ID: 21252068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in atherosclerosis in mice with elevated phospholipid transfer protein activity are related to decreased plasma high density lipoproteins and not to increased production of triglycerides.
    Lie J; Moerland M; van Gent T; van Haperen R; Scheek L; Sadeghi-Niaraki F; de Crom R; van Tol A
    Biochim Biophys Acta; 2006 Sep; 1761(9):1070-7. PubMed ID: 16935026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of phosphatidylethanolamine N-methyltransferase alters plasma VLDL phospholipids and attenuates atherosclerosis in mice.
    Zhao Y; Su B; Jacobs RL; Kennedy B; Francis GA; Waddington E; Brosnan JT; Vance JE; Vance DE
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1349-55. PubMed ID: 19520976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis.
    Christoffersen C; Pedersen TX; Gordts PL; Roebroek AJ; Dahlbäck B; Nielsen LB
    Circ Res; 2010 May; 106(10):1624-34. PubMed ID: 20360257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Important role for bone marrow-derived cholesteryl ester transfer protein in lipoprotein cholesterol redistribution and atherosclerotic lesion development in LDL receptor knockout mice.
    Van Eck M; Ye D; Hildebrand RB; Kar Kruijt J; de Haan W; Hoekstra M; Rensen PC; Ehnholm C; Jauhiainen M; Van Berkel TJ
    Circ Res; 2007 Mar; 100(5):678-85. PubMed ID: 17293475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia.
    Belalcazar LM; Merched A; Carr B; Oka K; Chen KH; Pastore L; Beaudet A; Chan L
    Circulation; 2003 Jun; 107(21):2726-32. PubMed ID: 12742997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.
    Mulvihill EE; Assini JM; Sutherland BG; DiMattia AS; Khami M; Koppes JB; Sawyez CG; Whitman SC; Huff MW
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):742-8. PubMed ID: 20110573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
    Westerterp M; van der Hoogt CC; de Haan W; Offerman EH; Dallinga-Thie GM; Jukema JW; Havekes LM; Rensen PC
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2552-9. PubMed ID: 16946130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel roles of hepatic lipase and phospholipid transfer protein in VLDL as well as HDL metabolism.
    van Haperen R; Samyn H; van Gent T; Zonneveld AJ; Moerland M; Grosveld F; Jansen H; Dallinga-Thie GM; van Tol A; de Crom R
    Biochim Biophys Acta; 2009 Oct; 1791(10):1031-6. PubMed ID: 19524061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased atherosclerotic lesions in apoE mice with plasma phospholipid transfer protein overexpression.
    Yang XP; Yan D; Qiao C; Liu RJ; Chen JG; Li J; Schneider M; Lagrost L; Xiao X; Jiang XC
    Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1601-7. PubMed ID: 12855484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
    Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased fecal bile acid excretion in transgenic mice with elevated expression of human phospholipid transfer protein.
    Post SM; de Crom R; van Haperen R; van Tol A; Princen HM
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):892-7. PubMed ID: 12649089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout mice.
    Parks BW; Lusis AJ; Kabarowski JH
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2703-9. PubMed ID: 16990555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-associated and extracellular phospholipid transfer protein in human coronary atherosclerosis.
    O'Brien KD; Vuletic S; McDonald TO; Wolfbauer G; Lewis K; Tu AY; Marcovina S; Wight TN; Chait A; Albers JJ
    Circulation; 2003 Jul; 108(3):270-4. PubMed ID: 12835223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the nuclear receptor PXR decreases plasma LDL-cholesterol levels and induces hepatic steatosis in LDL receptor knockout mice.
    Hoekstra M; Lammers B; Out R; Li Z; Van Eck M; Van Berkel TJ
    Mol Pharm; 2009; 6(1):182-9. PubMed ID: 19183106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.